Skip to content

Clinical trials

Inflammatory Bowel Diseases trials in Norway

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Inflammatory Bowel Diseases Country / region: Norway Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20061
20092
20101
20113
20132
20141
20171
20181
20201
20212
20222
20231
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Active, not recruiting3
Recruiting3
Terminated3
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Oslo University Hospital6
Eli Lilly and Company2
AbbVie1
GlaxoSmithKline1
Helse Møre og Romsdal HF1
Helse Stavanger HF1
InDex Pharmaceuticals1
Janssen Research & Development, LLC1
Merck Sharp & Dohme LLC1
Region Örebro County1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Inflammatory Bowel Diseases22
Colitis, Ulcerative10
Crohn Disease10
Colorectal Neoplasms2
Gastrointestinal Diseases2
Irritable Bowel Syndrome2
Colitis1
Disease1
Gastroenteritis1
Recurrence1

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.